For young people living with HIV in Cape Town, the daily ritual of swallowing pills has long been one of the hardest parts of staying healthy. A new study suggests there may be a way to lift that burden. When 134 young people aged 12 to 24 switched from daily tablets to long-acting injections of cabotegravir and rilpivirine, nearly all of them kept their virus under control. Every single participant who reached the end of the study chose to keep receiving the shots.
